No Data
Daqing Huake: 2024 Annual Performance Forecast of Daqing Huake Co., Ltd.
Daqing Huake (000985.SZ): plans to transfer the machinery and equipment Assets of its pharmaceutical subsidiary.
Gelonghui December 20丨Daqing Huake (000985.SZ) announced that in order to revitalize the existing Assets of Daqing Huake Co., Ltd. and effectively improve the utilization efficiency of fixed Assets, the company plans to dispose of some Assets as follows: 1. Through a property trading Institution, some Assets of the pharmaceutical branch will be publicly transferred, with a listing price not lower than the appraised value of 11.8351 million yuan, and no need to submit for Shareholder meeting approval. 2. The peripheral roads and green land of the pharmaceutical branch will be handed over to the government for compensated storage in a monetized compensation method, with a price not lower than the appraised value of 3.8338 million yuan.
Daqing Huake (000985.SZ): The company has not produced ultra-high molecular weight polyethylene fiber products.
Gelonghui reported on December 10 that daqing huake (000985.SZ) stated on the investor interaction platform that the company does not produce ultra-high molecular weight polyethylene fiber products.
Daqing Huake's (SZSE:000985) Solid Earnings Are Supported By Other Strong Factors
Daqing Huake Company Limited (SZSE:000985) Soars 35% But It's A Story Of Risk Vs Reward
Daqing Huake: Report for the third quarter of 2024
